Daratumumab in pediatric relapsed/refractory acute lymphoblastic leukemia or lymphoblastic lymphoma: the DELPHINUS study

Autor: Bhatla, Teena 1, ∗, Hogan, Laura E. 2, Teachey, David T. 3, Bautista, Francisco 4, 5, Moppett, John 6, Velasco Puyó, Pablo 7, Micalizzi, Concetta 8, Rossig, Claudia 9, Shukla, Neerav 10, Gilad, Gil 11, 12, Locatelli, Franco 13, Baruchel, André 14, Zwaan, C. Michel 4, 15, Bezler, Natalie S. 16, Rubio-San-Simón, Alba 5, Taussig, David C. 17, Raetz, Elizabeth A. 18, Mao, Zhengwei J. 19, Wood, Brent L. 19, Alvarez Arias, Diana 20, Krevvata, Maria 20, Nnane, Ivo 20, Bandyopadhyay, Nibedita 21, Lopez Solano, Lorena 21, Dennis, Robyn M. 21, Carson, Robin 20, Vora, Ajay 22
Zdroj: In Blood 21 November 2024 144(21):2237-2247
Databáze: ScienceDirect